HHS Secretary Xavier Becerra (Jacquelyn Martin/AP Images)
February 15, 2023 07:04 AM EST
Pharma
FDA+

In a first, CMS will test pay­ing less for drugs cleared via ac­cel­er­at­ed ap­proval

Zachary Brennan

Senior Editor

The Cen­ters for Medicare and Med­ic­aid Ser­vices said Tues­day af­ter­noon that it will start test­ing a pro­gram to pay drug­mak­ers less for drugs ap­proved via …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

Take­da to pay $200M for rights to ane­mia drug from Keros

Janux soars on ear­ly prostate can­cer da­ta that could chal­lenge No­var­tis' Plu­vic­to

Rev­o­lu­tion sells $600M in shares on back of RAS in­hibitor port­fo­lio up­dates

Roche teams up with Chica­go au­toim­mune biotech COUR Phar­ma­ceu­ti­cals

Gilead makes an­oth­er ADC move, ink­ing up to $415M pact with Tubu­lis

Ipsen se­cures rights to pre­clin­i­cal T cell en­gager in $610M pact with French biotech

A service from the Financial Times